CBSC activates China manufacturing pipeline and advances MyCardia AT into final NMPA submission phase with Ebulent Medical.

Jan 15

Cardiac Biotech

Cardiac Biotech

Cardiac Biotech Solutions Activates China Production Pipeline for MyCardia AT and Moves into Final NMPA Submission Phase

CBSC activates China manufacturing pipeline and enters final NMPA submission phase for MyCardia AT cardiac monitoring device.

May 08

Cardiac Biotech

Cardiac Biotech

CB Scientific, Inc. (CBSC) Announces Corporate Name Change to Cardiac Biotech Solutions, Inc.

CB Scientific, Inc. is now Cardiac Biotech Solutions, Inc., reflecting our mission to deliver advanced, cloud-connected cardiac monitoring technologies across global healthcare markets.

How can we help you?

Contact Us

© 2020-2026. Cardiac Biotech Solutions, Inc. - All rights reserved. | Designer

Get our news in your inbox!

Join our newsletter and we will send our news directly to you.